
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Human Cancer Biology |
Authors' Affiliations: 1 Experimental Oncology, 2 Pathology, 3 Ufficio Operativo, and 4 Department of Surgery, Fondazione IRCCS "Istituto Nazionale dei Tumori", and 5 Institute of Pathology, University of Milan, Milan, Italy, 6 Departments of Biomedicine and Anatomy, University of Kuopio, 7 Department of Oncology and Pathology, Kuopio University Hospital, and 8 Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Kuopio, Kuopio, Finland
Requests for reprints: Sylvie Ménard, Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy. Phone: 39-2239-2571; Fax: 39-2236-2692; E-mail: sylvie.menard{at}istitutotumori.mi.it.
Purpose: Local relapse (LR) remains an important concern in breast cancer surveillance. Given the unique opportunity to study local recurrences in the breast in the absence of irradiation, we tested the possibility of identifying a particular tumor feature that might account for LR.
Experimental Design: Archival specimens from 235 patients belonging to the control arm (no radiotherapy) of the Milan 3 Trial were retrieved and included in this study. H&E-stained histologic slides were reviewed for diagnostic reassessment. A panel of biological variables was assessed by immunohistochemical/cytochemical staining.
Results: Onset of LR was significantly linked only to patient's age, with a hazard ratio (HR) to relapse reduced by 60% in patients >50 years of age (P = 0.002). Univariate and multivariate Cox analyses in women
50 years of age indicated that only expression of hyaluronan in tumor cells was associated with LR risk (HR, 2.48; P = 0.0364 and HR, 2.34; P = 0.0580, respectively). In patients >50 years of age, lymph node and estrogen receptor status were significantly predictive of LR (HR, 3.34; P = 0.0113 and HR, 0.39; P = 0.0424, respectively). Multivariate analysis indicated that apart from lymph node positivity (HR, 3.48; P = 0.0120), none of the variables associated with LR in univariate analysis displayed an independent LR-predictive power. LR had a strong prognostic impact on distant metastasis in patients >50 years of age, whereas in younger women, LR did not affect the risk of metastasis.
Conclusions: These results support the notion that LR arises from two distinct mechanisms, one that is more frequent in young patients, associated with host characteristics, and is not linked with prognosis, and another that is less frequent, but is associated with tumor aggressiveness which represents a peculiar and distinct marker of breast tumor malignancy.
This article has been cited by other articles:
![]() |
A. Merlo, P. Casalini, M. L. Carcangiu, C. Malventano, T. Triulzi, S. Menard, E. Tagliabue, and A. Balsari FOXP3 Expression and Overall Survival in Breast Cancer J. Clin. Oncol., April 10, 2009; 27(11): 1746 - 1752. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lusa, B. Peissel, S. Manoukian, E. Marchesi, P. Radice, M. A. Pierotti, and M. Gariboldi Re: Molecular Basis for Estrogen Receptor {alpha} Deficiency in BRCA1-Linked Breast Cancer J Natl Cancer Inst, May 21, 2008; 100(10): 752 - 753. [Full Text] [PDF] |
||||
![]() |
A. M. Hosey, J. J. Gorski, J. E. Quinn, W. Y. Chung, A. Mccann, and D. P. Harkin Response: Re: Molecular Basis for Estrogen Receptor {alpha} Deficiency in BRCA1-Linked Breast Cancer J Natl Cancer Inst, May 21, 2008; 100(10): 753 - 754. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |